You are here

Changing attitudes towards cannabis medical properties

The WHO is recommending that cannabis and its resin be removed from Schedule IV, the most restrictive category of a 1961 drug convention that governs international treaties.


LITTLE illustrates the mania for cannabis investments better than the unprecedented demand over the stock symbol POT, but new recommendations from the World Health Organization (WHO) suggest some of that frenzy may not be unwarranted.

Tiny Vancouver-based cannabis company...